SONOSCAPE(SZ:300633) Xin Lang Cai Jing·2026-01-19 01:31Group 1 - The core viewpoint of the news is that Kaili Medical has experienced a decline in stock price and financing activities, indicating potential challenges in its financial performance and market perception [1][2]. Group 2 - On January 16, Kaili Medical's stock fell by 3.13%, with a trading volume of 154 million yuan. The net financing buy was -9.43 million yuan, with a total financing balance of 138 million yuan, which is 1.11% of its market capitalization [1]. - As of September 30, 2025, Kaili Medical reported a revenue of 1.459 billion yuan, a year-on-year increase of 4.37%, while the net profit attributable to shareholders decreased by 69.25% to 33.51 million yuan [2]. - The company has distributed a total of 381 million yuan in dividends since its A-share listing, with 258 million yuan distributed in the last three years [3]. Group 3 - As of September 30, 2025, the number of shareholders increased by 12.75% to 16,100, while the average circulating shares per person decreased by 11.31% to 26,824 shares [2]. - Among the top ten circulating shareholders, Hong Kong Central Clearing Limited increased its holdings by 1.7193 million shares to 7.4004 million shares, while Huabao Zhongzheng Medical ETF reduced its holdings by 1.0673 million shares to 6.1194 million shares [3].